ISL
AVEO

Ingalls & Snyder LLC’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Ingalls & Snyder LLC’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,539
Closed -$26K – 381
2015
Q2 		$26K Buy
+1,539
New +$27.7K ﹤0.01% 371

Other funds holding AVEO

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
GX
Greylock XI Cambridge, Massachusetts $7.71M AUM 28.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ingalls & Snyder LLC's AVEO Position: Q3 2015 in Review

Ingalls & Snyder LLC sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2015, closing a stake of 1,539 shares — an estimated $26K sold.

Ingalls & Snyder LLC first reported a position in AVEO in Q2 2015 and held it in 1 quarter. The position peaked at $26K in Q2 2015. 48 funds tracked by Wall St. Rank hold AVEO as of Q3 2015.

  • Ingalls & Snyder LLC reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 1,539 AVEO Pharmaceuticals, Inc. shares in Q3 2015, an estimated $26K.
  • Ingalls & Snyder LLC first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2015 and held it in 1 quarter.
  • Ingalls & Snyder LLC's AVEO Pharmaceuticals, Inc. position peaked at $26K in Q2 2015.
  • 48 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2015.

Based on Ingalls & Snyder LLC's 13F filing for Q3 2015, filed 27 Oct 2015.